DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $55,622,000 | +3.8% | 385,111 | +2.7% | 0.90% | -4.4% |
| Q2 2019 | $53,605,000 | -15.7% | 375,068 | -22.2% | 0.95% | -19.0% |
| Q1 2019 | $63,623,000 | +27.0% | 481,917 | -0.8% | 1.17% | +15.4% |
| Q4 2018 | $50,101,000 | -11.7% | 485,855 | -7.0% | 1.01% | +3.9% |
| Q3 2018 | $56,749,000 | +9.1% | 522,265 | -1.0% | 0.97% | +4.7% |
| Q2 2018 | $52,036,000 | -11.0% | 527,324 | -11.7% | 0.93% | -10.7% |
| Q1 2018 | $58,475,000 | +2.2% | 597,237 | -3.2% | 1.04% | +6.6% |
| Q4 2017 | $57,240,000 | +7.2% | 616,678 | -1.0% | 0.98% | +2.3% |
| Q3 2017 | $53,410,000 | +1.9% | 622,638 | +0.3% | 0.96% | -1.4% |
| Q2 2017 | $52,392,000 | -1.2% | 620,831 | +0.1% | 0.97% | -1.9% |
| Q1 2017 | $53,051,000 | +10.0% | 620,265 | +0.1% | 0.99% | +5.8% |
| Q4 2016 | $48,211,000 | -2.5% | 619,357 | -1.8% | 0.93% | -4.1% |
| Q3 2016 | $49,443,000 | +7.5% | 630,736 | +38.5% | 0.97% | +2.2% |
| Q2 2016 | $45,988,000 | +6.0% | 455,326 | -0.4% | 0.95% | +3.6% |
| Q1 2016 | $43,384,000 | -5.2% | 457,350 | -7.2% | 0.92% | -7.4% |
| Q4 2015 | $45,766,000 | -3.2% | 492,745 | -11.2% | 0.99% | -4.1% |
| Q3 2015 | $47,272,000 | +17.9% | 554,765 | +18.4% | 1.04% | +27.7% |
| Q2 2015 | $40,109,000 | -34.5% | 468,613 | -35.0% | 0.81% | -32.3% |
| Q1 2015 | $61,208,000 | -12.4% | 720,944 | -11.6% | 1.20% | -19.8% |
| Q4 2014 | $69,882,000 | +8.5% | 815,329 | -3.8% | 1.50% | +5.5% |
| Q3 2014 | $64,391,000 | +16.3% | 847,479 | +20.5% | 1.42% | +24.9% |
| Q2 2014 | $55,381,000 | +3.6% | 703,427 | -1.3% | 1.14% | +11.6% |
| Q1 2014 | $53,474,000 | -6.1% | 712,980 | -3.3% | 1.02% | -7.7% |
| Q4 2013 | $56,925,000 | -9.3% | 737,371 | -18.5% | 1.10% | -16.9% |
| Q3 2013 | $62,751,000 | +12.5% | 905,230 | +2.7% | 1.33% | +8.8% |
| Q2 2013 | $55,782,000 | – | 881,234 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |